AAREYDRUGS.NSAAREYDRUGS.NSNSE
Loading
Year-over-year net income growth rate
Percentile
P15
Within normal range
vs 2Y Ago
-0.3x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -44.37% |
| Q3 2025 | -25.34% |
| Q2 2025 | 191.70% |
| Q1 2025 | -34.53% |
| Q4 2024 | -55.03% |
| Q3 2024 | 28.84% |
| Q2 2024 | -42.42% |
| Q1 2024 | 12.79% |
| Q4 2023 | 143.14% |
| Q3 2023 | 8.28% |
| Q2 2023 | 102.88% |
| Q1 2023 | -27.77% |
| Q4 2022 | -76.67% |
| Q3 2022 | 164.87% |
| Q2 2022 | 205.93% |
| Q1 2022 | -138.77% |
| Q4 2021 | -31.50% |
| Q3 2021 | 13.35% |
| Q2 2021 | 78.33% |
| Q1 2021 | -17.41% |
| Q4 2020 | -7.72% |
| Q3 2020 | 35.86% |
| Q2 2020 | 36.46% |
| Q1 2020 | -29.00% |
| Q4 2019 | 8.12% |
| Q3 2019 | -38.22% |
| Q2 2019 | 185.41% |
| Q1 2019 | -52.68% |
| Q4 2018 | -27.73% |
| Q3 2018 | 2.35% |
| Q2 2018 | 157.45% |
| Q1 2018 | -54.74% |
| Q4 2017 | 9.13% |
| Q3 2017 | -13.26% |
| Q2 2017 | 41.91% |
| Q1 2017 | -23.49% |
| Q4 2016 | 4.23% |
| Q3 2016 | 52.90% |
| Q2 2016 | 2984.31% |
| Q1 2016 | -82.21% |